Maria Bălăeţ
Biographic Data
| ID | 1837158 |
|---|---|
| NAME | Maria Bălăeţ |
| GIVEN NAMES | Maria |
| FAMILY NAME | Bălăeţ |
| SIGNATURE | BĂLĂEŢ M |
| AFFILIATIONS | Imperial College London |
| ORCID | 0000-0002-0562-6139 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Public priorities in psychedelics research
This commentary explores public priorities in psychedelic research, drawing insights from extensive conversations between the author and the general public during lectures and seminars across the UK. Two primary themes emerged from this exchange: areas where further research is desired and concerns about the current direction of psychedelic research. Key topics of interest include psychedelics' effects on neurodivergent individuals, ageing, pain …
Considering the nocebo effect in the psychedelic discourse
This commentary addresses the potential for a nocebo effect arising from the public discourse on psychedelics, especially considering the increasing interest and engagement with these substances. The resurgence of psychedelics in the public and scientific arenas has led to a proliferation of discussions, both positive and cautionary, about their use. However, an imbalance in this discourse, particularly a focus on potential harms without adequate…
Associations between the use of psychedelics and other recreational drugs with mental health and resilience during the Covid-19 pandemic
The large-scale disruption to peoples' daily lives during the COVID-19 pandemic provides a context for examining whether use of substances such as psychedelics in a naturalistic (outside of a controlled environment) setting, is associated with better mental wellbeing and resilience relative to those who use other drugs, or who do not use drugs at all. We interrogate data from the Great British Intelligence Test and identify that 7.8% out of N = 3…
No prominent works on this page.
Associations between the use of psychedelics and other recreational drugs with mental health and resilience during the Covid-19 pandemic
The large-scale disruption to peoples' daily lives during the COVID-19 pandemic provides a context for examining whether use of substances such as psychedelics in a naturalistic (outside of a controlled environment) setting, is associated with better mental wellbeing and resilience relative to those who use other drugs, or who do not use drugs at all. We interrogate data from the Great British Intelligence Test and identify that 7.8% out of N = 3…
Considering the nocebo effect in the psychedelic discourse
This commentary addresses the potential for a nocebo effect arising from the public discourse on psychedelics, especially considering the increasing interest and engagement with these substances. The resurgence of psychedelics in the public and scientific arenas has led to a proliferation of discussions, both positive and cautionary, about their use. However, an imbalance in this discourse, particularly a focus on potential harms without adequate…
Public priorities in psychedelics research
This commentary explores public priorities in psychedelic research, drawing insights from extensive conversations between the author and the general public during lectures and seminars across the UK. Two primary themes emerged from this exchange: areas where further research is desired and concerns about the current direction of psychedelic research. Key topics of interest include psychedelics' effects on neurodivergent individuals, ageing, pain …
Psychedelics and Drug Studies (3 works) · Psychology (3 works) · Medicine (2 works) · Aesthetics (1 work) · Alternative medicine (1 work) · Art (1 work) · Cannabis (1 work) · Cannabis and Cannabinoid Research (1 work) · Clinical Psychology (1 work) · Clinical Psychology (1 work)